Singapore markets close in 1 hour 43 minutes
Straits Times Index
3,176.09 -11.57 (-0.36%) Nikkei
37,068.35 -1,011.35 (-2.66%) Hang Seng
16,226.12 -159.75 (-0.98%) FTSE 100
7,841.92 -35.13 (-0.45%) Bitcoin USD
64,311.72 +3,084.57 (+5.04%) CMC Crypto 200
1,333.00 +20.37 (+1.58%)
TScan Therapeutics, Inc. (TCRX)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 6.75 |
| Open | 6.65 |
| Bid | 6.85 x 100 |
| Ask | 6.95 x 200 |
| Day's range | 6.65 - 7.14 |
| 52-week range | 1.62 - 9.00 |
| Volume | |
| Avg. volume | 192,222 |
| Market cap | 331.501M |
| Beta (5Y monthly) | 0.90 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Hedge funds investors control 50% of TScan Therapeutics, Inc. (NASDAQ:TCRX) and were rewarded last week after stock increased 16%
Key Insights Significantly high institutional ownership implies TScan Therapeutics' stock price is sensitive to their...
- GuruFocus.com
TScan Therapeutics Inc (TCRX) Reports Increased Revenue and Expands Clinical Pipeline
Fourth Quarter and Full Year 2023 Financial Results and Business Developments
- Zacks
TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Tops Revenue Estimates
TScan Therapeutics, Inc. (TCRX) delivered earnings and revenue surprises of 30% and 145.02%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
© 2024 Yahoo. All rights reserved.